Meanwhile, inhibition of YAP or BCL-xL (TW37, ABT-263) synergistically increased the cytotoxic effect of RAF and MEK inhibitors on NSCLC cells [91]. Here, MAP2K7 is linked to non-small cell lung carcinoma.